The largest database of trusted experimental protocols

Albumin cre alb cre mice

Manufactured by Jackson ImmunoResearch
Sourced in United States

Albumin-Cre (Alb-Cre) mice are a transgenic mouse line that expresses the Cre recombinase enzyme under the control of the albumin promoter. This allows for the targeted deletion or modification of genes specifically in hepatocytes, the main cell type in the liver.

Automatically generated - may contain errors

8 protocols using albumin cre alb cre mice

1

Generation of vFlip-expressing Hepatocyte Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The generation of mice carrying a FLAG-tagged HHV8-vFlip flanked by a loxP-flanked neoR-STOP cassette and a frt-flanked IRES-GFP sequence in an ubiquitously expressed ROSA26 locus (Rosa26.vFlip mice) was described earlier20 (link). Transgenic mice expressing vFlip in hepatocytes were generated by breeding Rosa26.vFlip mice to Albumin-Cre (AlbCre) mice (B6.Cg-Speer6-ps1Tg(AlbCre)21Mgn/J) obtained from the Jackson Laboratory. Throughout the whole manuscript, we used AlbCre negative littermate controls to exclude strain-dependent differences in susceptibility. Reporter mice expressing tdTomato in hepatocytes were generated by crossing Rosa26.tdTomato, as described before21 (link), to Albumin-Cre mice. Mice were routinely screened for pathogens according to FELASA guidelines.
+ Open protocol
+ Expand
2

Hepatocyte-Specific Retinoid Receptor Alpha Knockout

Check if the same lab product or an alternative is used in the 5 most similar protocols
The floxed Rarα (Rarαfl/fl) mice (on a C57BL/6 background) were generously gifted by Dr. Yasmine Balkaid (National Institutes of Health/National Institute of Allergy and Infectious Diseases) and have been previously described by Dr. Chambon and colleagues.[10] Albumin cre (Alb‐Cre) mice were purchased from the Jackson Laboratory. Rarαfl/fl mice were crossed with Alb‐cre mice to generate germline hepatocyte‐specific Rarα−/− (gL‐Rarα−/−) and control littermates (Rarαfl/fl mice). AAV8‐TBG‐Null or AAV8‐TBG‐Cre was intravenously injected to 8‐week‐old male Rarαfl/fl mice to generate control mice (Rarαfl/fl) or adult‐onset hepatocyte‐specific Rarα−/− (L‐Rarα−/−) mice, respectively. Some of the mice were also gavaged with either vehicle (0.5% carboxymethyl cellulose) or AtRA (15 mg/kg/day).[7] All mice were housed in a temperature and humidity‐controlled room with a 12‐h light/12‐h dark cycle under pathogen‐free conditions. Mice are fasted for 5–6 h during the light cycle before euthanasia. All animal experiments were approved by the Institutional Animal Care and Use Committee at Northeast Ohio Medical University.
+ Open protocol
+ Expand
3

APAP-Induced Liver Injury in Liver-Specific mTOR and Raptor KO Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Albumin-Cre (Alb-Cre) mice, mTORf/f and Raptorf/f mice (C57BL/6J background) were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and crossbred to produce liver-specific mTOR KO (L-mTOR, Alb Cre+/−, mTORf/f) and liver-specific Raptor KO (L-Raptor, Alb Cre+/−, Raptor f/f) mice. Alb-Cre littermates were used as wild-type (WT) mice. Only male mice were used for the studies as female mice are known to be resistant to APAP-induced liver injury.
For animal experiments, APAP (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in saline and warmed to ensure its complete dissolution prior to injection. Mice were caged with free access to chow food and water in 12/12 light cycle. Male 8–12 weeks old L-mTOR KO, L-Raptor KO and their matched WT mice were injected with 500 mg/kg of APAP i. p. in the morning, and the mice were euthanized 6, 24 and 48 h after APAP injection. Matched volume of saline was injected as control.
+ Open protocol
+ Expand
4

Hepatocyte-Specific Arid1a Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatocyte-specific Arid1a knockout (Arid1aLKO) C57BL/6 mice were generated by mating Arid1afl/fl mice (kindly provided by Zhong Wang at the Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School) with Albumin-Cre (Alb-Cre) mice (from the Jackson Laboratory). The littermate Arid1afl/fl mice were served as controls. The Arid1afl allele enables to delete the eighth exon of Arid1a in the presence of Cre recombinase, leading to a frameshift mutation and nonsense-mediated mRNA decay [21 (link)]. Five- to 7-week-old Ubc-CreERT2; Arid1afl/fl C57BL/6 mice and littermate control Arid1afl/fl mice were administered 1 mg of tamoxifen (T5648, Sigma) dissolved in sunflower oil via intraperitoneal injection for five consecutive days. All animals were randomly grouped. Mice genotype identification was as previously described [21 (link)].
+ Open protocol
+ Expand
5

Generation of Conditional Knockout TRIM31 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate mice with a conditional knockout allele of TRIM31, the TRIM31Flox/Flox mice with C57BL/6 N background were constructed using CRISPR/Cas9-regulated genome engineering system. The exon 4/5 of TRIM31 was selected as conditional knockout region (cKO). Briefly, the selected exons of TRIM31 were flanked by two loxP sites, and therefore two single guide RNAs (gRNA1# and gRNA2#) targeting TRIM31 introns were designed. The targeting vector containing TRIM31 exon 4/5 flanked by two loxP sites and the two homology arms was used as the template. The targeting vector, gRNA1# and gRNA2#, and together with Cas9 were co-injected into fertilized eggs for cKO mouse production. The obtained mice, which had exon 4/5 flanked by two loxP sites on one allele, were used to establish TRIM31Flox/Flox mice. Hepatocyte-specific TRIM31 deletion (TRIM31Hep-cKO) mice were produced by mating TRIM31Flox/Flox mice with albumin-Cre (Alb-Cre) mice (Jackson Laboratory, Bar Harbor, Maine, USA). A simple schematic diagram has been indicated in Supplementary Fig. S13A. TRIM31Flox/Flox (Flox) mice littermates were used in the work as controls for the obtained TRIM31Hep-cKO mice. All TRIM31Flox/Flox and TRIM31Hep-cKO mice were then randomly divided into three subgroups, including the Oil/Veh group (n = 15), CCl4/Veh group (n = 20), and CCl4/Mul-H (high dosage 60 mg/kg; n = 15) group.
+ Open protocol
+ Expand
6

APAP-Induced Liver Injury in Liver-Specific mTOR and Raptor KO Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Albumin-Cre (Alb-Cre) mice, mTORf/f and Raptorf/f mice (C57BL/6J background) were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and crossbred to produce liver-specific mTOR KO (L-mTOR, Alb Cre+/−, mTORf/f) and liver-specific Raptor KO (L-Raptor, Alb Cre+/−, Raptor f/f) mice. Alb-Cre littermates were used as wild-type (WT) mice. Only male mice were used for the studies as female mice are known to be resistant to APAP-induced liver injury.
For animal experiments, APAP (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in saline and warmed to ensure its complete dissolution prior to injection. Mice were caged with free access to chow food and water in 12/12 light cycle. Male 8–12 weeks old L-mTOR KO, L-Raptor KO and their matched WT mice were injected with 500 mg/kg of APAP i. p. in the morning, and the mice were euthanized 6, 24 and 48 h after APAP injection. Matched volume of saline was injected as control.
+ Open protocol
+ Expand
7

Liver-specific Sirt6 knockout mouse model

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J mice, albumin-cre (alb-cre) mice (stock # 003574), and Ldlr−/− mice (stock # 002207) were purchased from Jackson Laboratory (Bar Harbor, ME, USA) on a C57BL/6J background. The Sirt6fl/fl mice were described previously [3 (link)]. Sirt6fl/fl mice were crossed with albumin-Cre mice to generate liver-specific Sirt6−/− mice (Sirt6Hep−/−) and control (Sirt6fl/fl) mice. Sirt6fl/fl mice and Ldlr−/− mice were cross-bred to generate Sirt6fl/flLdlr−/− mice. A Western diet containing 21% fat/0.2% cholesterol (stock # TD.88137) was purchased from Envigo (Indianapolis, IN, USA). Unless otherwise stated, about two-month-old male mice were fed this special diet for four months and fasted for 5–6 h during the light cycle prior to anesthesia. All animal studies complied with the ARRIVE guidelines and were approved by the Institutional Animal Care and Use Committee at Northeast Ohio Medical University.
+ Open protocol
+ Expand
8

Hepatocyte-specific miR-34a Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-34afl/fl mice, albumin-Cre (Alb-Cre) mice, and C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, Maine, USA) [4 (link)]. miR-34afl/fl mice were crossed with Alb-Cre mice to generate germline hepatocyte-specific miR-34a−/− (miR-34agHep−/−) mice and control littermates (miR-34afl/fl mice). AAV8-TBG-Null or AAV8-TBG-Cre was i.v. injected into the miR-34afl/fl mice to generate control mice (miR-34afl/fl mice) or adult-onset hepatocyte-specific miR-34a−/− (miR-34aHep−/−) mice, respectively. Locked nucleic acids (LNA) against scramble sequences (LNA-Scr) or miR-34a (LNA-miR-34a) were synthesized by Qiagen and i.p. injected into the mice at a dosage of 10 mg/kg/week. All of the mice were housed in a temperature- and humidity-controlled room with a 12-h light/12-h dark cycle under pathogen-free conditions. The high-fat/cholesterol/fructose (HFCF) diet contained 40% fat/0.2% cholesterol (AIN-76A Western diet from TestDiet) and 4.2% fructose (in drinking water). Unless otherwise stated, 2-month-old male mice were used and fed an HFCF diet for 16 weeks. The mice were fasted for 5–6 h during the light cycle prior to euthanasia. All the of animal experiments were approved by the Institutional Animal Care and Use Committee at Northeast Ohio Medical University (NEOMED).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!